First Commonwealth Financial Corp’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.9M | Buy |
7,565
+221
| +3% | +$47.5K | 0.27% | 66 |
|
|
2026
Q1 | $1.6M | Buy |
7,344
+613
| +9% | +$136K | 0.25% | 71 |
|
|
2025
Q4 | $1.54M | Sell |
6,731
-699
| -9% | -$159K | 0.25% | 72 |
|
|
2025
Q3 | $1.72M | Sell |
7,430
-211
| -3% | -$43K | 0.29% | 58 |
|
|
2025
Q2 | $1.42M | Buy |
7,641
+82
| +1% | +$15.2K | 0.31% | 57 |
|
|
2025
Q1 | $1.58M | Buy |
7,559
+352
| +5% | +$68.4K | 0.37% | 53 |
|
|
2024
Q4 | $1.28M | Buy |
7,207
+167
| +2% | +$30.7K | 0.3% | 59 |
|
|
2024
Q3 | $1.39M | Sell |
7,040
-32
| -0.5% | -$5.97K | 0.33% | 51 |
|
|
2024
Q2 | $1.21M | Buy |
7,072
+733
| +12% | +$121K | 0.31% | 56 |
|
|
2024
Q1 | $1.15M | Sell |
6,339
-597
| -9% | -$103K | 0.31% | 58 |
|
|
2023
Q4 | $1.07M | Sell |
6,936
-216
| -3% | -$31.5K | 0.33% | 47 |
|
|
2023
Q3 | $1.07M | Buy |
7,152
+346
| +5% | +$50.8K | 0.36% | 48 |
|
|
2023
Q2 | $917K | Buy |
6,806
+217
| +3% | +$31.8K | 0.3% | 60 |
|
|
2023
Q1 | $1.05M | Sell |
6,589
-141
| -2% | -$21.6K | 0.38% | 54 |
|
|
2022
Q4 | $1.09M | Buy |
6,730
+4,069
| +153% | +$624K | 0.4% | 48 |
|
|
2022
Q3 | $357K | Hold |
2,661
| – | – | 0.15% | 130 |
|
|
2022
Q2 | $408K | Sell |
2,661
-499
| -16% | -$76.2K | 0.15% | 130 |
|
|
2022
Q1 | $512K | Hold |
3,160
| – | – | 0.16% | 116 |
|
|
2021
Q4 | $428K | Sell |
3,160
-1
| -0% | -$118 | 0.14% | 126 |
|
|
2021
Q3 | $341K | Sell |
3,161
-1
| -0% | -$114 | 0.12% | 136 |
|
|
2021
Q2 | $357K | Buy |
3,162
+350
| +12% | +$39.4K | 0.13% | 134 |
|
|
2021
Q1 | $305K | Buy |
2,812
+19
| +0.7% | +$2.03K | 0.12% | 138 |
|
|
2020
Q4 | $299K | Buy |
2,793
+25
| +0.9% | +$2.4K | 0.13% | 136 |
|
|
2020
Q3 | $243K | Buy |
2,768
+499
| +22% | +$47K | 0.11% | 146 |
|
|
2020
Q2 | $223K | Buy |
+2,269
| New | +$200K | 0.11% | 152 |
|
|
2019
Q1 | – | Sell |
-4,727
| Closed | -$436K | – | 142 |
|
|
2018
Q4 | $436K | Hold |
4,727
| – | – | 0.31% | 86 |
|
|
2018
Q3 | $447K | Buy |
4,727
+58
| +1% | +$5.5K | 0.3% | 85 |
|
|
2018
Q2 | $433K | Sell |
4,669
-208
| -4% | -$20.3K | 0.45% | 71 |
|
|
2018
Q1 | $462K | Buy |
+4,877
| New | +$536K | 0.49% | 63 |
|
Other funds holding ABBV
First Commonwealth Financial Corp's ABBV Position: Q2 2026 in Review
First Commonwealth Financial Corp increased its AbbVie (ABBV) stake by 3% in Q2 2026, buying an estimated $47.5K and bringing the position to 7,565 shares worth $1.9M. The position accounts for 0.27% of the portfolio, ranked #66.
First Commonwealth Financial Corp first reported a position in ABBV in Q1 2018 and has held it in 29 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- First Commonwealth Financial Corp held 7,565 shares of AbbVie worth $1.9M as of Q2 2026.
- First Commonwealth Financial Corp bought 221 AbbVie shares in Q2 2026, an estimated $47.5K.
- AbbVie made up 0.27% of First Commonwealth Financial Corp's portfolio in Q2 2026, its #66 holding.
- First Commonwealth Financial Corp first reported a position in AbbVie in Q1 2018 and has held it in 29 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on First Commonwealth Financial Corp's 13F filing for Q2 2026, filed 12 Aug 2026.